NO20054102L - Vaksiner avledet fra epitelial celle mucin Muc-1 - Google Patents

Vaksiner avledet fra epitelial celle mucin Muc-1

Info

Publication number
NO20054102L
NO20054102L NO20054102A NO20054102A NO20054102L NO 20054102 L NO20054102 L NO 20054102L NO 20054102 A NO20054102 A NO 20054102A NO 20054102 A NO20054102 A NO 20054102A NO 20054102 L NO20054102 L NO 20054102L
Authority
NO
Norway
Prior art keywords
epithelial cell
muc
vaccines derived
cell mucin
mucin muc
Prior art date
Application number
NO20054102A
Other languages
English (en)
Norwegian (no)
Other versions
NO20054102D0 (no
Inventor
Paul A Hamblin
Maria De Los Angeles Roch Cura
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20054102D0 publication Critical patent/NO20054102D0/no
Publication of NO20054102L publication Critical patent/NO20054102L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
NO20054102A 2003-02-28 2005-09-02 Vaksiner avledet fra epitelial celle mucin Muc-1 NO20054102L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0304634.9A GB0304634D0 (en) 2003-02-28 2003-02-28 Vaccines
PCT/EP2004/002007 WO2004076665A2 (en) 2003-02-28 2004-02-26 Vaccines derived from epithelial cell mucin muc-1

Publications (2)

Publication Number Publication Date
NO20054102D0 NO20054102D0 (no) 2005-09-02
NO20054102L true NO20054102L (no) 2005-09-27

Family

ID=9953871

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054102A NO20054102L (no) 2003-02-28 2005-09-02 Vaksiner avledet fra epitelial celle mucin Muc-1

Country Status (18)

Country Link
US (1) US20060147458A1 (de)
EP (1) EP1597368A2 (de)
JP (1) JP2007524352A (de)
KR (1) KR20050107472A (de)
CN (1) CN1753994A (de)
AU (1) AU2004215187A1 (de)
BR (1) BRPI0407601A (de)
CA (1) CA2517062A1 (de)
CO (1) CO5670372A2 (de)
GB (1) GB0304634D0 (de)
IS (1) IS7956A (de)
MA (1) MA27746A1 (de)
MX (1) MXPA05009160A (de)
NO (1) NO20054102L (de)
PL (1) PL378761A1 (de)
RU (1) RU2005125608A (de)
WO (1) WO2004076665A2 (de)
ZA (1) ZA200506548B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0617387D0 (en) * 2006-09-04 2006-10-11 Glaxo Group Ltd Synthetic gene
CN103570821A (zh) * 2012-07-27 2014-02-12 北京智飞绿竹生物制药有限公司 粘蛋白-1抗原性多肽及其作为肿瘤疫苗的用途
CN110198733B (zh) 2016-09-28 2024-04-30 巴法里安诺迪克有限公司 用于增强痘病毒中转基因的稳定性的组合物和方法
CN113321724B (zh) * 2021-03-24 2022-02-01 深圳市新靶向生物科技有限公司 一种与食道癌驱动基因突变相关的抗原肽及其应用
US20250057946A1 (en) * 2021-12-20 2025-02-20 Zoetis Services Llc Use of interferon as an adjuvant in vaccines
CN116535488A (zh) * 2023-04-17 2023-08-04 北京世纪沃德生物科技有限公司 一种重组kl-6质控品蛋白及其质控品和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM322393A0 (en) * 1993-12-24 1994-01-27 Austin Research Institute, The Mucin carbohydrate compounds and their use in immunotherapy
US6548643B1 (en) * 1994-11-16 2003-04-15 Austin Research Institute Antigen carbohydrate compounds and their use in immunotherapy
IL125608A0 (en) * 1998-07-30 1999-03-12 Yeda Res & Dev Tumor associated antigen peptides and use of same as anti-tumor vaccines
CA2383737C (en) * 1999-09-08 2011-01-18 Transgene S.A. Muc-1 derived peptides
GB9930359D0 (en) * 1999-12-22 2000-02-09 Glaxo Group Ltd Novel polypeptides
JP2003533181A (ja) * 2000-02-01 2003-11-11 ジ・オースティン・リサーチ・インスティテュート ムチン−１誘導抗原および免疫療法におけるその使用
GB0212046D0 (en) * 2002-05-24 2002-07-03 Glaxo Group Ltd Vaccines
GB0212036D0 (en) * 2002-05-24 2002-07-03 Glaxo Group Ltd Vaccines
GB0321614D0 (en) * 2003-09-15 2003-10-15 Glaxo Group Ltd Vaccines

Also Published As

Publication number Publication date
CN1753994A (zh) 2006-03-29
ZA200506548B (en) 2007-12-27
US20060147458A1 (en) 2006-07-06
AU2004215187A1 (en) 2004-09-10
CO5670372A2 (es) 2006-08-31
EP1597368A2 (de) 2005-11-23
MXPA05009160A (es) 2005-10-20
NO20054102D0 (no) 2005-09-02
JP2007524352A (ja) 2007-08-30
PL378761A1 (pl) 2006-05-15
CA2517062A1 (en) 2004-09-10
RU2005125608A (ru) 2006-03-27
KR20050107472A (ko) 2005-11-11
IS7956A (is) 2005-07-25
BRPI0407601A (pt) 2006-02-14
WO2004076665A2 (en) 2004-09-10
MA27746A1 (fr) 2006-02-01
GB0304634D0 (en) 2003-04-02
WO2004076665A3 (en) 2005-02-24

Similar Documents

Publication Publication Date Title
CY1122330T1 (el) Συνθεσεις δισκιων μηλεϊνικης νερατινιμπης
EA201171287A1 (ru) Жидкие составы солей 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазина
UA112281C2 (uk) Стабільні інсектицидні композиції і способи їх отримання
BR112012013193A2 (pt) composição oral contendo zizyphus joazeiro e métodos relacionados
MX2010004813A (es) Factor viii recombinante que tiene estabilidad incrementada.
CY1113282T1 (el) Αντιικα νουκλεοζιτικα αναλογα
BR112015018508A2 (pt) moduladores de enzimas modificadoras de metila, suas composições e uso
IT1402650B1 (it) Procedimento per preparare da se' il pane, macchina per il pane e relativa scatola di ingredienti per il pane.
EA201190306A1 (ru) Улучшенная липидная композиция
BR112012017345A2 (pt) "composições e métodos de pgl para a produção aumentada de isopreno e outros produtos com 6-fosfogliconolactonase (pgl)"
BR112015021993A8 (pt) polipeptídeo, métodos para sua produção, métodos para cultivo de uma célula, composição farmacêutica, kit, e meio de cultura celular
PA8792401A1 (es) Fenilendiaminas
BR112014014319A2 (pt) composições de cuidado oral
CY1113257T1 (el) Παραγωγα βενζυλοπιπεραζινης τα οποια ειναι χρησιμα στη θεραπεια γαστρεντερικων διαταραχων
NO20062709L (no) Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller
TR200908237A2 (tr) Kalsiyum ve D vitamini içeren farmasötik bileşimler.
NO20081470L (no) Polypeptider som har antimikrobeaktivitet og polynukleotider som koder for disse.
NO20054102L (no) Vaksiner avledet fra epitelial celle mucin Muc-1
ITTO20110273A1 (it) Composizione di base per composizione cosmetica oppure farmaceutica.
CY1119468T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιεχουν αλισποριβιρη
ATE503491T1 (de) Verbesserte anthraximpfstoffe und abgabeverfahren
FR2941232B1 (fr) Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
BRPI0417205A (pt) composições farmacêuticas
NO20063611L (no) Fremgangsmater for fremstilling av aryl- og heteroarylsulfonylhalider
CY1114823T1 (el) Φαινυλ-αλκυλ πιπεραζινες οι οποιες διαθετουν μια ρυθμιστικη δραστηριοτητα του τνf

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application